Vendor review
ZePeptide reviews
ZePeptide reviews from 97 independent lab tests (Retatrutide, GHK-Cu and BPC-157): grade A, purity and fill accuracy. Is ZePeptide legit? See what its vials showed.
What the lab tests show
97 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 8, 2026 | PT-141 | 99.9 % | 11 mg of 10 mg (10 %) | Pass | View |
| Sep 24, 2026 | NAD+ | 1000 mg | Fail | View | |
| Sep 24, 2026 | MOTS-c | 99.7 % | 33.7 mg of 40 mg (-16 %) | Pass | View |
| Sep 16, 2026 | Retatrutide | 99.8 % | 4.5 mg of 10 mg (-55 %) | Pass | View |
| Sep 7, 2026 | Retatrutide | 99.8 % | 14.9 mg of 20 mg (-26 %) | Pass | View |
| Sep 4, 2026 | MOTS-c | 10 mg | Fail | View | |
| Aug 31, 2026 | Retatrutide | 30 mg | Fail | View | |
| Aug 25, 2026 | Tesamorelin | 99.7 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Aug 13, 2026 | TB-500 | 10 mg | Fail | View | |
| Aug 9, 2026 | TB-500 | 99.6 % | 11.7 mg of 10 mg (17 %) | Pass | View |
| Aug 9, 2026 | BPC-157 | 99.6 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Aug 9, 2026 | BPC-157 | 10 mg | Fail | View | |
| Aug 9, 2026 | GHK-Cu | 99.7 % | 100.6 mg of 100 mg (1 %) | Pass | View |
| Aug 9, 2026 | Tirzepatide | 99.8 % | 11.3 mg of 10 mg (13 %) | Pass | View |
| Aug 5, 2026 | Retatrutide | 99.9 % | 29.5 mg of 30 mg (-2 %) | Pass | View |
| Aug 3, 2026 | BPC-157 | 10 mg | Fail | View | |
| Aug 3, 2026 | TB-500 | 5 mg | Fail | View | |
| Aug 3, 2026 | GHK-Cu | 99.9 % | 36.5 mg of 100 mg (-64 %) | Pass | View |
| Aug 3, 2026 | MOTS-c | 99.3 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Jul 20, 2026 | Tirzepatide | 30 mg | Fail | View | |
| Jul 20, 2026 | Tirzepatide | 99.8 % | 22.8 mg of 20 mg (14 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 30 mg | Fail | View | |
| Jul 20, 2026 | Retatrutide | 99.9 % | 8.66 mg of 10 mg (-13 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 99.9 % | 8.9 mg of 10 mg (-11 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 10 mg | Fail | View | |
| Jul 20, 2026 | Retatrutide | 85.1 % | 19.3 mg of 20 mg (-3 %) | Pass | View |
| Jul 13, 2026 | BPC-157 | 99.9 % | 9.29 mg of 10 mg (-7 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.8 % | 23.6 mg of 20 mg (18 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.9 % | 16.4 mg of 15 mg (9 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.9 % | 18.7 mg of 20 mg (-7 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.7 % | 13.6 mg of 10 mg (36 %) | Pass | View |
| Jul 13, 2026 | GHK-Cu | 99.9 % | 42.9 mg of 50 mg (-14 %) | Pass | View |
| Jul 10, 2026 | Tesamorelin | 99.7 % | 11.5 mg of 10 mg (15 %) | Pass | View |
| Jul 10, 2026 | Retatrutide | 98.2 % | 23.5 mg of 30 mg (-22 %) | Pass | View |
| Jul 10, 2026 | GHK-Cu | 99.7 % | 84.9 mg of 100 mg (-15 %) | Pass | View |
| Jul 1, 2026 | Retatrutide | 99.9 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Jul 1, 2026 | Wolverine | 99.4 % | 16 mg of 20 mg (-20 %) | Pass | View |
| Jun 26, 2026 | Retatrutide | 10 mg | View | ||
| Jun 26, 2026 | Retatrutide | 10 mg | Fail | View | |
| Jun 23, 2026 | NAD+ | 500 mg | Fail | View | |
| Jun 23, 2026 | NAD+ | 96.8 % | 53 mg of 500 mg (-89 %) | Pass | View |
| Jun 22, 2026 | Wolverine | 20 mg | Fail | View | |
| Jun 17, 2026 | Retatrutide | 99.8 % | 18.3 mg of 20 mg (-9 %) | Pass | View |
| Jun 15, 2026 | Retatrutide | 20 mg | Fail | View | |
| Jun 8, 2026 | TB-500 | 10 mg | Fail | View | |
| Jun 8, 2026 | Retatrutide | 20 mg | Fail | View | |
| Jun 8, 2026 | Retatrutide | 99.7 % | 9.9 mg of 10 mg (-1 %) | Pass | View |
| May 28, 2026 | Tirzepatide | 99.9 % | 11.2 mg of 10 mg (12 %) | Pass | View |
| May 28, 2026 | Retatrutide | 99.9 % | 9.81 mg of 10 mg (-2 %) | Pass | View |
| May 20, 2026 | Tirzepatide | 99.9 % | 9.74 mg of 10 mg (-3 %) | Pass | View |
| May 20, 2026 | Retatrutide | 99.9 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| May 13, 2026 | GHK-Cu | 99.3 % | 105 mg of 100 mg (5 %) | Pass | View |
| May 9, 2026 | Wolverine | 20 mg | Fail | View | |
| May 8, 2026 | Retatrutide | 99.5 % | 21.7 mg of 20 mg (9 %) | Pass | View |
| May 8, 2026 | Retatrutide | 99.9 % | 24.9 mg of 30 mg (-17 %) | Pass | View |
| May 6, 2026 | Tesamorelin | 99.9 % | 7.15 mg of 10 mg (-29 %) | Pass | View |
| May 5, 2026 | Retatrutide | 99.9 % | 25.7 mg of 30 mg (-14 %) | Pass | View |
| Apr 28, 2026 | TB-500 | 99.9 % | 5.33 mg of 5 mg (7 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 6.56 mg of 7 mg (-6 %) | Pass | View |
| Apr 28, 2026 | BPC-157 | 99.6 % | 9.4 mg of 10 mg (-6 %) | Pass | View |
What ZePeptide sells
No current listings on record.
About ZePeptide
Finnrick has tested 97 samples from ZePeptide across 11 products.